Brief: Atara Biotherapeutics Q1 EPS USD -0.23
09/05/2024 21:01
May 09 (Reuters) - Atara Biotherapeutics Q1 net income USD -31.752 million. * Q1 revenue USD 27.357 million * Q1 operating income USD -31.247 million
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing